Ignite Creation Date:
2025-12-25 @ 1:11 AM
Ignite Modification Date:
2025-12-25 @ 11:22 PM
Study NCT ID:
NCT06745193
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-20
First Post:
2024-12-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer
Sponsor:
Peking University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-02-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-17
First Submit QC Date:
None
Study First Post Date:
2024-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-17
Last Update Post Date:
2024-12-20
Last Update Post Date Type:
ACTUAL